Concepedia

CHANG-HONG PANG

CP

Statistics

Publications

5

Citations

131

H-Index

5

Active since

1994

Affiliations

Pfizer (United States)(Current)

Pfizer (Japan)

CHANG-HONG PANG is an author at Pfizer (United States) specializing in life sciences, microbiology, and fungal enzyme inhibitors.

Publications per year

1994–2005

5

Publications

5

CJ-21,058, a New SecA Inhibitor Isolated from a Fungus.

Yutaka Sugie, SAE INAGAKI, Yoshinao Kato et al. · The Journal of Antibiotics · 2002 · 65 citations · Full text

, , +8

Production of 6,8a-Seco-6,8a-deoxy Derivatives of Avermectins by a Mutant Strain of Streptomyces avermitilis.

CHANG-HONG PANG, Keiichi Matsuzaki, Haruo Ikeda et al. · The Journal of Antibiotics · 1995 · 28 citations · Full text

, , +5

Involvement of N-methyl-D-aspartate-type glutamate receptor ε1 and ε4 subunits in tonic inflammatory pain and neuropathic pain

Masanori Hizue, CHANG-HONG PANG, Masayuki Yokoyama · Neuroreport · 2005 · 14 citations

, , +16

Cosmid Vector for Cloning and Analysis of Streptomyces DNA.

CHANG-HONG PANG, Masako Shiiyama, Haruo Ikeda et al. · Actinomycetologica · 1994 · 13 citations · Full text

, , +4

CJ-21,164, a New D-Glucose-6-phosphate Phosphohydrolase Inhibitor Produced by a Fungus Chloridium sp.

Yoon-Jeong Kim, Hiroyuki Nishida, CHANG-HONG PANG et al. · The Journal of Antibiotics · 2002 · 11 citations · Full text

, , +12

1–5 of 5